Early Changes In Waivered Clinicians & Utilization of Buprenorphine For Opioid Use Disorder After Implementation Of The 2021 HHS Buprenorphine Practice Guideline

On December 2, 2022, the U.S. Department of Health and Human Services (HHS) published this report on early changes in waivered clinicians and utilization of buprenorphine for opioid use disorder after implementation of the 2021 HHS buprenorphine practice guidelines. This brief addresses both of these research questions by examining changes in clinician waiver uptake and the number of patients receiving buprenorphine from pharmacies for OUD treatment in the early months after the Practice Guidelines took effect (i.e., between June 2021 and December 2021 . . .